Kathleen Calati

Statistics

Publications

Citations

228

H-Index

Active since

2008

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (Spain)

Kathleen Calati is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in antifungal agents, fungal biochemistry, and natural antifungal compounds.

Publications per year

2008–2014

Publications

Isolation and Structure Elucidation of Parnafungins, Antifungal Natural Products that Inhibit mRNA Polyadenylation

Craig A. Parish, Scott K. Smith, Kathleen Calati et al. · Journal of the American Chemical Society · 2008 · 92 citations

Life Sciences, Microbiology, Pharmacology +17

Discovery of the parnafungins, antifungal metabolites that inhibit mRNA polyadenylation, from the<i>Fusarium larvarum</i>complex and other Hypocrealean fungi

Gerald F. Bills, Gonzalo Platas, David P. Overy et al. · Mycologia · 2009 · 56 citations

Life Sciences, Biology, Microbiology +17

Isolation and structure elucidation of parnafungins C and D, isoxazolidinone-containing antifungal natural products

David P. Overy, Kathleen Calati, Jennifer Nielsen Kahn et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 34 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Application of Affinity Selection/Mass Spectrometry to Determine the Structural Isomer of Parnafungins Responsible for Binding Polyadenosine Polymerase

Gregory C. Adam, Craig A. Parish, Douglas Wisniewski et al. · Journal of the American Chemical Society · 2008 · 27 citations

Life Sciences, Microbiology, Molecular Biology +17

Improving the In Vivo Therapeutic Index of siRNA Polymer Conjugates through Increasing pH Responsiveness

Erin N. Guidry, Julie Farand, Arash Soheili et al. · Bioconjugate Chemistry · 2014 · 19 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

1–5 of 5